Search results
Why 4 new bird flu developments have experts worried about the virus
Business Insider via Yahoo News· 6 days agoFurthermore, scientists now have proven mRNA vaccine technology at the ready. Vaccines that use mRNA...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 4 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Gateway - Quartz
Quartz· 1 day agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Gateway - Quartz
Quartz· 19 hours agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an early-phase clinical trial testing the combined use of an experimental cancer vaccine ...
Gateway - Quartz
Quartz· 19 hours agoModerna says it is in talks about receiving U.S. government funding for its bird flu vaccine trial. Merck said that it is acquiring Eyebiotech (EyeBio) for $3 billion, as ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Gateway - Quartz
Quartz· 11 hours agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both announced billion-dollar ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Vaxart Stock Is Moving Higher After The Bell: What's Going On? - Vaxart (NASDAQ:VXRT)
Benzinga· 1 day agoWhat Happened: Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant...
